Skip to main content
FinSpry Logo
FinSpry
QGEN logo
QGEN
(NYSE)
Qiagen N.V.
$35.09-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Qiagen (QGEN) Stock Price & Financial Analysis

Qiagen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$33.79 - $35.12
52-Week High$57.82
52-Week Low$32.61
Open$34.31
Volume1.64M
Average Volume (3M)2.25M
Market Cap7.49B
Shares Outstanding218.88M
P/E Ratio (TTM)17.64
Forward P/E8.59
Price to Sales (P/S)3.59
Price to Book (P/B)1.98
EV/EBITDA13.11
Revenue (TTM)2.09B
Net Income (TTM)424.88M
Free Cash Flow (TTM)452.27M
EPS (TTM)$2.04
Profit Margin20.33%
Operating Margin26.43%
Return on Equity (ROE)11.25%
Debt to Equity0.44
50-Day MA$39.53
200-Day MA$46.43
52-Week Change-24.05%
Annual Dividend$2.66
Dividend Yield7.58%
Payout Ratio130.21%
Last Dividend Ex-DateJul 7, 2026

Frequently Asked Questions About Qiagen

What is the current stock price for QGEN?

As of the latest trading session, QGEN stock trades at $35.09. The 52-week range is $32.61–$57.82, with a day range of $33.79–$35.12.

What is the P/E ratio for QGEN?

Qiagen's trailing P/E ratio is 17.6, meaning investors pay $17.6 for every $1 of annual earnings. The forward P/E is 8.6, reflecting analyst expectations for future earnings. Qiagen operates in the Healthcare sector.

Does QGEN pay dividends?

Yes, Qiagen pays a 7.58% annual dividend yield ($2.66 per share). The payout ratio is 130.2%. The last ex-dividend date was 2026-07-07.

What do analysts recommend for QGEN?

Based on 5 analysts, the consensus for QGEN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of QGEN?

Qiagen's market capitalization is $7.68B, classifying it as a mid-cap company. Qiagen operates in the Healthcare sector within the Diagnostics & Research industry.